The purpose of this study is to observe the clinical manifestation, Lab findings including chest CT scans, pathological findings and outcomes in chinese patients with pulminary vasculitis.
Presentation of patient with suspected vasculitis 1. Established diagnosis Clinical findings Laboratory workup Tissue biopsy Angiogram where appropriate 2. Evaluating respiratory system Chest HRCT Pulmonary function test Bronchoscopy exam(BALF, TBB) Lung biopsy(needle biopsy, VAST) 3. screening underlying damage to other system Paranasal sinus, vision \& audition Nervous system Kidney Gastrointestinal tract Heart \& vessel Skin Hematology Muscle, bone \& joint 4. Treatment 5. Prognosis Evaluation 1. Study visits occurred at baseline; at weeks 4; and at 2, 4, 6,12,18,24,30 months. 2. Disease activity was measured on the basis of the BVAS/WG and the physician's global assessment. 3. Damage related to disease or treatment was scored according to the Vasculitis Damage Index (scores for this index range from 0 to 64, with higher scores in- dicating more severe damage). 4. Health related quality of life was scored with the use of the Med- ical Outcomes Study 36-Item Short-Form Health Survey (SF-36).Scores on this scale range from 0 to 100, with higher scores indicating better health. 5. Serial serum samples were tested for proteinase 3-ANCA and myeloperoxidase-ANCA by means of a direct enzyme-linked immunosorbent assay (ELISA).
Study Type
OBSERVATIONAL
Enrollment
100
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Completely Remission
BVAS/WG of 0 and successful completion of the prednisone taper at 6 months.
Time frame: 6 months
Disease flare
Disease flare 1. an increase in the BVAS/WG of 1 point or more. 2. Patients were classified as having early treatment failure if at 1 month their BVAS/WG had not decreased by at least 1 point or a new manifestation of disease had emerged.
Time frame: during the period of observation(30months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.